Cargando…
Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer
BACKGROUND: Wnt-2 plays an oncogenic role in cancer, but which Frizzled receptor(s) mediates the Wnt-2 signaling pathway in lung cancer remains unclear. We sought to (1) identify and evaluate the activation of Wnt-2 signaling through Frizzled-8 in non-small cell lung cancer, and (2) test whether a n...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707790/ https://www.ncbi.nlm.nih.gov/pubmed/23815780 http://dx.doi.org/10.1186/1471-2407-13-316 |
_version_ | 1782276536539283456 |
---|---|
author | Bravo, Dawn T Yang, Yi-Lin Kuchenbecker, Kristopher Hung, Ming-Szu Xu, Zhidong Jablons, David M You, Liang |
author_facet | Bravo, Dawn T Yang, Yi-Lin Kuchenbecker, Kristopher Hung, Ming-Szu Xu, Zhidong Jablons, David M You, Liang |
author_sort | Bravo, Dawn T |
collection | PubMed |
description | BACKGROUND: Wnt-2 plays an oncogenic role in cancer, but which Frizzled receptor(s) mediates the Wnt-2 signaling pathway in lung cancer remains unclear. We sought to (1) identify and evaluate the activation of Wnt-2 signaling through Frizzled-8 in non-small cell lung cancer, and (2) test whether a novel expression construct dominant negative Wnt-2 (dnhWnt-2) reduces tumor growth in a colony formation assay and in a xenograft mouse model. METHODS: Semi-quantitative RT-PCR was used to identify the expression of Wnt-2 and Frizzled-8 in 50 lung cancer tissues from patients. The TCF reporter assay (TOP/FOP) was used to detect the activation of the Wnt canonical pathway in vitro. A novel dnhWnt-2 construct was designed and used to inhibit activation of Wnt-2 signaling through Frizzled-8 in 293T, 293, A549 and A427 cells and in a xenograft mouse model. Statistical comparisons were made using Student’s t-test. RESULTS: Among the 50 lung cancer samples, we identified a 91% correlation between the transcriptional increase of Wnt-2 and Frizzled-8 (p<0.05). The Wnt canonical pathway was activated when both Wnt-2 and Frizzled-8 were co-expressed in 293T, 293, A549 and A427 cells. The dnhWnt-2 construct we used inhibited the activation of Wnt-2 signaling in 293T, 293, A549 and A427 cells, and reduced the colony formation of NSCLC cells when β-catenin was present (p<0.05). Inhibition of Wnt-2 activation by the dnhWnt-2 construct further reduced the size and mass of tumors in the xenograft mouse model (p<0.05). The inhibition also decreased the expression of target genes of Wnt signaling in these tumors. CONCLUSIONS: We demonstrated an activation of Wnt-2 signaling via the Frizzled-8 receptor in NSCLC cells. A novel dnhWnt-2 construct significantly inhibits Wnt-2 signaling, reduces colony formation of NSCLC cells in vitro and tumor growth in a xenograft mouse model. The dnhWnt-2 construct may provide a new therapeutic avenue for targeting the Wnt pathway in lung cancer. |
format | Online Article Text |
id | pubmed-3707790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37077902013-07-11 Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer Bravo, Dawn T Yang, Yi-Lin Kuchenbecker, Kristopher Hung, Ming-Szu Xu, Zhidong Jablons, David M You, Liang BMC Cancer Research Article BACKGROUND: Wnt-2 plays an oncogenic role in cancer, but which Frizzled receptor(s) mediates the Wnt-2 signaling pathway in lung cancer remains unclear. We sought to (1) identify and evaluate the activation of Wnt-2 signaling through Frizzled-8 in non-small cell lung cancer, and (2) test whether a novel expression construct dominant negative Wnt-2 (dnhWnt-2) reduces tumor growth in a colony formation assay and in a xenograft mouse model. METHODS: Semi-quantitative RT-PCR was used to identify the expression of Wnt-2 and Frizzled-8 in 50 lung cancer tissues from patients. The TCF reporter assay (TOP/FOP) was used to detect the activation of the Wnt canonical pathway in vitro. A novel dnhWnt-2 construct was designed and used to inhibit activation of Wnt-2 signaling through Frizzled-8 in 293T, 293, A549 and A427 cells and in a xenograft mouse model. Statistical comparisons were made using Student’s t-test. RESULTS: Among the 50 lung cancer samples, we identified a 91% correlation between the transcriptional increase of Wnt-2 and Frizzled-8 (p<0.05). The Wnt canonical pathway was activated when both Wnt-2 and Frizzled-8 were co-expressed in 293T, 293, A549 and A427 cells. The dnhWnt-2 construct we used inhibited the activation of Wnt-2 signaling in 293T, 293, A549 and A427 cells, and reduced the colony formation of NSCLC cells when β-catenin was present (p<0.05). Inhibition of Wnt-2 activation by the dnhWnt-2 construct further reduced the size and mass of tumors in the xenograft mouse model (p<0.05). The inhibition also decreased the expression of target genes of Wnt signaling in these tumors. CONCLUSIONS: We demonstrated an activation of Wnt-2 signaling via the Frizzled-8 receptor in NSCLC cells. A novel dnhWnt-2 construct significantly inhibits Wnt-2 signaling, reduces colony formation of NSCLC cells in vitro and tumor growth in a xenograft mouse model. The dnhWnt-2 construct may provide a new therapeutic avenue for targeting the Wnt pathway in lung cancer. BioMed Central 2013-07-01 /pmc/articles/PMC3707790/ /pubmed/23815780 http://dx.doi.org/10.1186/1471-2407-13-316 Text en Copyright © 2013 Bravo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bravo, Dawn T Yang, Yi-Lin Kuchenbecker, Kristopher Hung, Ming-Szu Xu, Zhidong Jablons, David M You, Liang Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer |
title | Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer |
title_full | Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer |
title_fullStr | Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer |
title_full_unstemmed | Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer |
title_short | Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer |
title_sort | frizzled-8 receptor is activated by the wnt-2 ligand in non-small cell lung cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707790/ https://www.ncbi.nlm.nih.gov/pubmed/23815780 http://dx.doi.org/10.1186/1471-2407-13-316 |
work_keys_str_mv | AT bravodawnt frizzled8receptorisactivatedbythewnt2ligandinnonsmallcelllungcancer AT yangyilin frizzled8receptorisactivatedbythewnt2ligandinnonsmallcelllungcancer AT kuchenbeckerkristopher frizzled8receptorisactivatedbythewnt2ligandinnonsmallcelllungcancer AT hungmingszu frizzled8receptorisactivatedbythewnt2ligandinnonsmallcelllungcancer AT xuzhidong frizzled8receptorisactivatedbythewnt2ligandinnonsmallcelllungcancer AT jablonsdavidm frizzled8receptorisactivatedbythewnt2ligandinnonsmallcelllungcancer AT youliang frizzled8receptorisactivatedbythewnt2ligandinnonsmallcelllungcancer |